Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen W Ma

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Journal of Clinical Oncology|November 17, 2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract CancerRenuka V Iyer, Venkata K Pokuri, Adrienne Groman, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2013
Physiologically based pharmacokinetic models for everolimus and sorafenib in miceDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomenKilian Salerno May, Nikhil I Khushalani, Rameela Chandrasekhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancerColin D Weekes, Daniel D Von Hoff, Alex A Adjei, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Journal of Clinical Oncology|November 17, 2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract CancerRenuka V Iyer, Venkata K Pokuri, Adrienne Groman, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2013
Physiologically based pharmacokinetic models for everolimus and sorafenib in miceDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomenKilian Salerno May, Nikhil I Khushalani, Rameela Chandrasekhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancerColin D Weekes, Daniel D Von Hoff, Alex A Adjei, et al.
Pageof 2